1. Home
  2. ITCI vs CNA Comparison

ITCI vs CNA Comparison

Compare ITCI & CNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITCI
  • CNA
  • Stock Information
  • Founded
  • ITCI 2002
  • CNA 1853
  • Country
  • ITCI United States
  • CNA United States
  • Employees
  • ITCI N/A
  • CNA N/A
  • Industry
  • ITCI Biotechnology: Pharmaceutical Preparations
  • CNA Property-Casualty Insurers
  • Sector
  • ITCI Health Care
  • CNA Finance
  • Exchange
  • ITCI Nasdaq
  • CNA Nasdaq
  • Market Cap
  • ITCI 13.5B
  • CNA 13.3B
  • IPO Year
  • ITCI N/A
  • CNA N/A
  • Fundamental
  • Price
  • ITCI $126.97
  • CNA $49.00
  • Analyst Decision
  • ITCI Buy
  • CNA Sell
  • Analyst Count
  • ITCI 13
  • CNA 2
  • Target Price
  • ITCI $103.62
  • CNA $51.00
  • AVG Volume (30 Days)
  • ITCI 5.8M
  • CNA 221.0K
  • Earning Date
  • ITCI 02-20-2025
  • CNA 02-10-2025
  • Dividend Yield
  • ITCI N/A
  • CNA 3.60%
  • EPS Growth
  • ITCI N/A
  • CNA 20.94
  • EPS
  • ITCI N/A
  • CNA 4.79
  • Revenue
  • ITCI $613,728,000.00
  • CNA $14,088,000,000.00
  • Revenue This Year
  • ITCI $48.43
  • CNA N/A
  • Revenue Next Year
  • ITCI $38.10
  • CNA $8.88
  • P/E Ratio
  • ITCI N/A
  • CNA $10.17
  • Revenue Growth
  • ITCI 46.08
  • CNA 9.18
  • 52 Week Low
  • ITCI $62.78
  • CNA $42.33
  • 52 Week High
  • ITCI $128.00
  • CNA $52.36
  • Technical
  • Relative Strength Index (RSI)
  • ITCI 84.04
  • CNA 52.97
  • Support Level
  • ITCI $126.88
  • CNA $47.99
  • Resistance Level
  • ITCI $127.36
  • CNA $49.25
  • Average True Range (ATR)
  • ITCI 0.44
  • CNA 0.78
  • MACD
  • ITCI -0.90
  • CNA 0.05
  • Stochastic Oscillator
  • ITCI 55.86
  • CNA 48.02

About ITCI Intra-Cellular Therapies Inc.

Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.

About CNA CNA Financial Corporation

CNA Financial Corporation (CNAF) is an insurance holding company that provides commercial property and casualty insurance. The company operates under five segments: Specialty, Commercial and International being its core business and two segments for its non-core businesses, which are Life and Group and Corporate and Other. CNAF, through its segments, provides professional, financial, specialty property and casualty products to small businesses and medium scale organizations. It has its business spread across Continental Europe, United Kingdom, and Canada. The majority of the revenues are generated from the Specialty and Commercial segment of the business.

Share on Social Networks: